{"id":"https://openalex.org/W4361949563","doi":"https://doi.org/10.1158/1078-0432.c.6518748.v1","title":"Data from Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non\u2013Small Cell Lung Cancer","display_name":"Data from Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non\u2013Small Cell Lung Cancer","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361949563","doi":"https://doi.org/10.1158/1078-0432.c.6518748.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.6518748.v1","doi":"https://doi.org/10.1158/1078-0432.c.6518748.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6518748.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1078-0432.c.6518748.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015618150","display_name":"Stefanie Hammer","orcid":"https://orcid.org/0000-0002-5635-9878","observed_orcids":["https://orcid.org/0000-0002-5635-9878"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stefanie Hammer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007299835","display_name":"Anette Sommer","orcid":"https://orcid.org/0000-0002-1576-3110","observed_orcids":["https://orcid.org/0000-0002-1576-3110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anette Sommer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109512554","display_name":"Iduna Fichtner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Iduna Fichtner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060122908","display_name":"Michael A. Becker","orcid":"https://orcid.org/0000-0002-9706-905X","observed_orcids":["https://orcid.org/0000-0002-9706-905X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Becker","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055396997","display_name":"Jana Rolff","orcid":"https://orcid.org/0000-0002-2364-3274","observed_orcids":["https://orcid.org/0000-0002-2364-3274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jana Rolff","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113855254","display_name":"Johannes Merk","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Johannes Merk","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034559941","display_name":"Ulrich Klar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ulrich Klar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5002682008","display_name":"Jens Hoffmann","orcid":"https://orcid.org/0000-0003-3880-1658","observed_orcids":["https://orcid.org/0000-0003-3880-1658"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jens Hoffmann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.8798999786376953,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.8798999786376953,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.030799999833106995,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.01510000042617321,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sagopilone","display_name":"sagopilone","score":0.9559999704360962},{"id":"https://openalex.org/keywords/epothilones","display_name":"epothilones","score":0.871999979019165},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9449999928474426},{"id":"https://openalex.org/keywords/drug-response-profiling","display_name":"drug response profiling","score":0.5540000200271606},{"id":"https://openalex.org/keywords/tubulin-isotypes","display_name":"tubulin isoforms","score":0.777999997138977},{"id":"https://openalex.org/keywords/mitotic-arrest","display_name":"mitotic arrest","score":0.8159999847412109},{"id":"https://openalex.org/keywords/wild-type-p53","display_name":"wild-type p53","score":0.7850000262260437},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7559999823570251},{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.8830000162124634},{"id":"https://openalex.org/keywords/sorafenib","display_name":"sorafenib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.734000027179718},{"id":"https://openalex.org/keywords/vegf-signaling","display_name":"VEGF signaling","score":0.8140000104904175},{"id":"https://openalex.org/keywords/preclinical-to-clinical-translation","display_name":"preclinical to clinical translation","score":0.6240000128746033}],"concepts":[{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6130960583686829},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5640991926193237},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.4824707806110382},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.4228648841381073},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4111367464065552},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.39595162868499756},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3922659158706665},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.24815255403518677},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2320190668106079},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.08954203128814697}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.c.6518748.v1","doi":"https://doi.org/10.1158/1078-0432.c.6518748.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6518748.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.6518748.v1","doi":"https://doi.org/10.1158/1078-0432.c.6518748.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.c.6518748.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2144327008","https://openalex.org/W1990784010","https://openalex.org/W1997522537","https://openalex.org/W2158385729","https://openalex.org/W2080780787","https://openalex.org/W2412426552","https://openalex.org/W2267566933","https://openalex.org/W4392725089","https://openalex.org/W2000779382","https://openalex.org/W2049501985"],"abstract_inverted_index":{"Abstract":[0],"Purpose:":[1],"Characterization":[2],"of":[3,33,53,102,107,133,167,176,231],"new":[4,54,239],"anticancer":[5,55],"drugs":[6,128,200,240],"in":[7,21,67,100,135,148,159,170,207,252],"a":[8,42,48,244],"few":[9],"xenograft":[10,104],"models":[11,75,105,111,117,209],"derived":[12],"from":[13,238],"established":[14,127],"human":[15],"cancer":[16,74],"cell":[17,72,137,171],"lines":[18],"frequently":[19],"results":[20,78],"the":[22,31,103,130,229],"discrepancy":[23],"between":[24],"preclinical":[25,43,223],"and":[26,76,81,115,198],"clinical":[27,51,91,253],"results.":[28],"To":[29],"take":[30],"heterogeneity":[32],"tumors":[34,163],"into":[35],"consideration":[36],"more":[37,49,180,234],"thoroughly,":[38],"we":[39],"describe":[40],"here":[41,220],"approach":[44],"that":[45,95],"may":[46],"allow":[47],"rational":[50],"development":[52],"drugs.":[56],"Experimental":[57],"Design:":[58],"We":[59],"tested":[60,251],"Sagopilone,":[61],"an":[62],"optimized":[63],"fully":[64],"synthetic":[65],"epothilone,":[66],"22":[68],"well-characterized":[69],"patient-derived":[70],"non\u2013small":[71,136],"lung":[73,138],"correlated":[77],"with":[79,109,123,164,196],"mutational":[80],"genome-wide":[82],"gene":[83,141],"expression":[84,142,166],"analysis.":[85],"Results:":[86],"Response":[87],"analysis":[88],"according":[89],"to":[90,155,182,185,249],"trial":[92],"criteria":[93],"revealed":[94],"Sagopilone":[96,134,144,186,193],"induced":[97,145],"overall":[98],"responses":[99],"64%":[101],"(14":[106],"22),":[108],"3":[110],"showing":[112,118],"stable":[113],"disease":[114],"11":[116],"partial":[119],"response.":[120],"A":[121],"comparison":[122],"response":[124],"rates":[125],"for":[126,228,246],"showed":[129],"strong":[131],"efficacy":[132],"cancer.":[139],"In":[140],"analyses,":[143],"tubulin":[146],"isoforms":[147],"all":[149],"tumor":[150],"samples,":[151],"but":[152],"genes":[153,168],"related":[154],"mitotic":[156],"arrest":[157],"only":[158],"responder":[160],"models.":[161],"Moreover,":[162],"high":[165],"involved":[169],"adhesion/angiogenesis":[172],"as":[173,175,241,243],"well":[174,242],"wild-type":[177],"TP53":[178],"were":[179],"likely":[181,235],"be":[183,215,250],"resistant":[184],"therapy.":[187],"As":[188],"suggested":[189],"by":[190],"these":[191],"findings,":[192],"was":[194],"combined":[195],"Bevacizumab":[197],"Sorafenib,":[199],"targeting":[201],"vascular":[202],"endothelial":[203],"growth":[204],"factor":[205],"signaling,":[206],"Sagopilone-resistant":[208],"and,":[210],"indeed,":[211],"antitumor":[212],"activity":[213],"could":[214],"restored.":[216],"Conclusion:":[217],"Analyses":[218],"provided":[219],"show":[221],"how":[222],"studies":[224],"can":[225],"provide":[226],"hypotheses":[227],"identification":[230],"patients":[232],"who":[233],"will":[236],"benefit":[237],"rationale":[245],"combination":[247],"therapies":[248],"trials.":[254],"Clin":[255],"Cancer":[256],"Res;":[257],"16(5);":[258],"1452\u201365":[259]},"counts_by_year":[],"updated_date":"2026-10-02T10:15:12.560889","created_date":"2023-04-05T00:00:00"}